VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Sofia, Bulgaria, March 24-25, 2011
Thursday, March 24, 2011
Session 1 Opening and objectives
Chair: Angel Kunchev, Mira Kojouharova
09.00 - 09.30
09.30 – 10.00
Impact of the hepatitis resolution adopted by the World Health Assembly (WHA 63.18) 236 Kb (.pdf)
Steven Wiersma
Session 2 The Health Care system in Bulgaria
Chair: Angela Dominguez , Nadezhda Vladimirova
10.30 – 10.50
Organisation and funding of the health system in Bulgaria 1.6 Mb (.pdf)
Tatiana Ivanova
10.50 – 11.10
National immunisation program 657Kb (.pdf)
Radosveta Filipova
11.10 – 11.30
Overview of communicable disease surveillance system in Bulgaria 872Kb (.pdf)
Mira Kojouharova
11.30 – 11.45
Healthcare Policy for vulnerable groups, especially Roma in Bulgaria 783 Kb (.pdf)
Rossitsa Ivanova
11.45 – 12.00
Concept of health mediators – history, job description and mediator’s activities 2.4 Mb (.pdf)
Ivailo Tarnev
12.00 – 12.20 Discussion
12.20 – 13.40 Lunch
Session 3 Epidemiology of viral hepatitis in Bulgaria
Chair: Wolfgang Jilg , Nina Gatcheva
13.40 – 14.00
Epidemiology of viral hepatitis in Bulgaria. 519 Kb (.pdf)
Nadezhda Vladimirova,
14.00 – 14.20
Molecular epidemiology of HBV and HCV. 1.9 Mb (.pdf)
Pavel Teoharov
14.20 – 14.40
Phylogenetic reconstruction of two large HAV outbreaks occurring simultaneously in different regions in Bulgaria 1.7 Mb (.pdf)
Anton Andonov
14.40 – 15.00
Seroepidemiological study on HBV and HCV prevalence in Bulgaria 1.7 Mb (.pdf)
Ani Kevorkian
15.00 – 15.20
Viral hepatitis and surveillance in Blood bank in Bulgaria. 1.5 Mb (.pdf)
Svetla Bakalova
15.20 – 15.30 Discussion
15.30 – 15.50 Lunch
Chair: Daniel Shouval , Tatiana Tcherveniakova
15.50 – 16.10
IDU risk group and viral hepatitis 2.8 Mb (.pdf)
Violeta Bogdanova
16.10– 16.30
Sero-epidemiology of viral hepatitis in haemodialysis and control measures 461 Kb (.pdf)
Evgueniy Vazelov, V. Mushekov
16.30– 16.50
Health care-associated viral hepatitis C. 1 Mb (.pdf)
Rossitza Vatcheva-Dobrevska
16.50– 17.10
Quality of life of patients with HBV infection – case study with SF-36. 453 Kb (.pdf)
Alexandra Tzenova-Savova
17.10– 17.30
Viral hepatitis- The patients’ impact in Bulgaria. (Hepasist). 1.2 Mb (.pdf)
Stanimir Hasurdjiev
17.30 – 17.45 Discussion
17.45 – 15.05 End of the Day
Friday, March 25, 2011
Session 4 Prevention and Control of viral hepatitis in Bulgaria
Chair: Mark Kane , Anton Andonov
09.00 – 09.20
Clinical aspects of viral hepatitis.3.9 Mb (.pdf)
Tatiana Tcherveniakova
09.20 – 09.40
Treatment and laboratory monitoring of chronic hepatitis patients in Bulgaria. 1.8 MB (pdf)
Krassimir Antonov
09.40 – 10.00
Control of viral hepatitis in haemodialysis.
Stefan Krivoshiev
10.00 – 10.20
Hepatitis A in city of Plovdiv in 2006 – outbreak investigation and control measures 1.9 Mb (.pdf)
Angel Kunchev, Monika Troyancheva
10.20 – 10.30 Discussion
10.30 – 10.50 Coffee break
Session 5 Evaluation of the Prevention and Control of Viral Hepatitis in Bulgaria
Chair:Liudmilla Mosina , Krassimir Antonov
10.50 – 11.10
National Hepatitis B vaccination programme: cost-benefit assessment of introduction of universal HBV vaccination of newborns in Bulgaria 454Kb (.pdf)
Anna Kurchatova
11.10 – 11.30
Epidemiological effectiveness of the universal newborn HBV vaccination: 20 years after. 89 Kb (.pdf)
Mira Kojouharova
11.30 – 11.50
Economic analysis of the universal HBV vaccination 20 years after introduction. 826 Kb (.pdf)
Guenka Petrova
11.50 – 12.10
Protection of medical staff through hepatitis B vaccination: serological and epidemiological data from hospitals in Bulgaria 1.4 Mb (.pdf)
Nina Gatcheva
12.10 – 12.30
Our experience in prevention by selective immunization against viral hepatitis A and B of the staff of Military Medical Academy – Bulgaria 1.8 Mb (.pdf)
Andrey Galev
12.30 – 12.45 Discussion
12.45 – 14.10 Lunch
Session 6 Conclusions of the meeting
Chair: Johannes Hallauer , Mira Kojouharova
14.15 – 15.15
Presentation of the VHPB meeting conclusions 64 Kb(.pdf)
David FitzSimons
15.15 Close of the meeting